EcoDrugPlus

Ensembl ID : ENSATEG00000000227
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSATEG00000000466
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSATEG00000001955
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSATEG00000000605
Gene Symbol: -
1 Cross references
219 Possible Orthologues:

Ensembl ID : ENSATEG00000000881
Gene Symbol: -
1 Cross references
510 Possible Orthologues:

Ensembl ID : ENSATEG00000001142
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSATEG00000002192
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSATEG00000002404
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSATEG00000000169
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSATEG00000017539
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSATEG00000004596
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSATEG00000017377
Gene Symbol: -
Cross references: -
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).